Elena Vendrame1, Christof Seiler2, Thanmayi Ranganath1, Nancy Q Zhao1,3, Rosemary Vergara1, Michel Alary4,5,6, Annie-Claude Labbé7,8, Fernand Guédou9, Johanne Poudrier10,11, Susan Holmes2, Michel Roger10,11, Catherine A Blish1,3,12. 1. Division of Infection Diseases and Geographic Medicine, Department of Medicine. 2. Department of Statistics. 3. Immunology Program, Stanford University, Stanford, California, USA. 4. Centre de recherche du CHU de Québec-Université Laval. 5. Département de Médecine Sociale et Préventive, Université Laval. 6. Institut National de Santé Publique du Québec, Québec. 7. Département de Microbiologie, Infectiologie et Immunologie de l'Université de Montréal. 8. Département de Microbiologie Médicale et Infectiologie, Hôpital Maisonneuve-Rosemont, Montréal. 9. Dispensaire IST, Cotonou, Bénin. 10. Laboratoire d'Immunogénétique, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM). 11. Département de Microbiologie, Infectiologie et Immunologie de l'Université de Montréal, Montréal, Canada. 12. Chan Zuckerberg Biohub, San Francisco, California, USA.
Abstract
OBJECTIVE: Our objective was to investigate the mechanisms that govern natural killer (NK)-cell responses to HIV, with a focus on specific receptor--ligand interactions involved in HIV recognition by NK cells. DESIGN AND METHODS: We first performed a mass cytometry-based screen of NK-cell receptor expression patterns in healthy controls and HIV individuals. We then focused mechanistic studies on the expression and function of T cell immunoreceptor with Ig and ITIM domains (TIGIT). RESULTS: The mass cytometry screen revealed that TIGIT is upregulated on NK cells of untreated HIV women, but not in antiretroviral-treated women. TIGIT is an inhibitory receptor that is thought to mark exhausted NK cells; however, blocking TIGIT did not improve anti-HIV NK-cell responses. In fact, the TIGIT ligands CD112 and CD155 were not upregulated on CD4 T cells in vitro or in vivo, providing an explanation for the lack of benefit from TIGIT blockade. TIGIT expression marked a unique subset of NK cells that express significantly higher levels of NK-cell-activating receptors (DNAM-1, NTB-A, 2B4, CD2) and exhibit a mature/adaptive phenotype (CD57, NKG2C, LILRB1, FcRγ, Syk). Furthermore, TIGIT NK cells had increased responses to mock-infected and HIV-infected autologous CD4 T cells, and to PMA/ionomycin, cytokine stimulation and the K562 cancer cell line. CONCLUSION: TIGIT expression is increased on NK cells from untreated HIV individuals. Although TIGIT does not participate directly to the response to HIV-infected cells, it marks a population of mature/adaptive NK cells with increased functional responses.
OBJECTIVE: Our objective was to investigate the mechanisms that govern natural killer (NK)-cell responses to HIV, with a focus on specific receptor--ligand interactions involved in HIV recognition by NK cells. DESIGN AND METHODS: We first performed a mass cytometry-based screen of NK-cell receptor expression patterns in healthy controls and HIV individuals. We then focused mechanistic studies on the expression and function of T cell immunoreceptor with Ig and ITIM domains (TIGIT). RESULTS: The mass cytometry screen revealed that TIGIT is upregulated on NK cells of untreated HIV women, but not in antiretroviral-treated women. TIGIT is an inhibitory receptor that is thought to mark exhausted NK cells; however, blocking TIGIT did not improve anti-HIV NK-cell responses. In fact, the TIGIT ligands CD112 and CD155 were not upregulated on CD4 T cells in vitro or in vivo, providing an explanation for the lack of benefit from TIGIT blockade. TIGIT expression marked a unique subset of NK cells that express significantly higher levels of NK-cell-activating receptors (DNAM-1, NTB-A, 2B4, CD2) and exhibit a mature/adaptive phenotype (CD57, NKG2C, LILRB1, FcRγ, Syk). Furthermore, TIGIT NK cells had increased responses to mock-infected and HIV-infected autologous CD4 T cells, and to PMA/ionomycin, cytokine stimulation and the K562cancer cell line. CONCLUSION:TIGIT expression is increased on NK cells from untreated HIV individuals. Although TIGIT does not participate directly to the response to HIV-infected cells, it marks a population of mature/adaptive NK cells with increased functional responses.
Authors: Elena Vendrame; Julia L McKechnie; Thanmayi Ranganath; Nancy Q Zhao; Arjun Rustagi; Rosemary Vergara; Geoffrey T Ivison; Lisa M Kronstad; Laura J Simpson; Catherine A Blish Journal: J Vis Exp Date: 2020-11-19 Impact factor: 1.355
Authors: Zuwena A Richardson; Claire Deleage; Candani S A Tutuka; Marzena Walkiewicz; Perla M Del Río-Estrada; Rachel D Pascoe; Vanessa A Evans; Gustavo Reyesteran; Michael Gonzales; Samuel Roberts-Thomson; Mauricio González-Navarro; Fernanda Torres-Ruiz; Jacob D Estes; Sharon R Lewin; Paul U Cameron Journal: J Immunol Methods Date: 2021-12-02 Impact factor: 2.287
Authors: Nancy Q Zhao; Anne-Maud Ferreira; Philip M Grant; Susan Holmes; Catherine A Blish Journal: Front Immunol Date: 2020-05-12 Impact factor: 7.561
Authors: Anne-Sophie Chretien; Raynier Devillier; Samuel Granjeaud; Charlotte Cordier; Clemence Demerle; Nassim Salem; Julia Wlosik; Florence Orlanducci; Laurent Gorvel; Stephane Fattori; Marie-Anne Hospital; Jihane Pakradouni; Emilie Gregori; Magali Paul; Philippe Rochigneux; Thomas Pagliardini; Mathieu Morey; Cyril Fauriat; Nicolas Dulphy; Antoine Toubert; Herve Luche; Marie Malissen; Didier Blaise; Jacques A Nunès; Norbert Vey; Daniel Olive Journal: Proc Natl Acad Sci U S A Date: 2021-06-01 Impact factor: 11.205
Authors: Levelle D Harris; Jeremiah Khayumbi; Joshua Ongalo; Loren E Sasser; Joan Tonui; Angela Campbell; Felix Hayara Odhiambo; Samuel Gurrion Ouma; Galit Alter; Neel R Gandhi; Cheryl L Day Journal: Front Cell Infect Microbiol Date: 2020-03-24 Impact factor: 5.293
Authors: Michelle Y-H Lee; Amit A Upadhyay; Hasse Walum; Chi N Chan; Reem A Dawoud; Christine Grech; Justin L Harper; Kirti A Karunakaran; Sydney A Nelson; Ernestine A Mahar; Kyndal L Goss; Diane G Carnathan; Barbara Cervasi; Kiran Gill; Gregory K Tharp; Elizabeth R Wonderlich; Vijayakumar Velu; Simon M Barratt-Boyes; Mirko Paiardini; Guido Silvestri; Jacob D Estes; Steven E Bosinger Journal: PLoS Pathog Date: 2021-06-28 Impact factor: 6.823